India Q2 Preview: Glenmark, Cipla Emerge Stronger

Remdesivir Sales Could Taper Slightly in Q3

 
• By Vibha Ravi
Forecast
Analysts Forecast Q2 Gains For Indian Firms Though Growth Will Be Uneven • Source: Shutterstock

More from Business

More from Scrip